REHABOTICS: Integrated Rehabilitation System for People With Motor Disabilities
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of the Rehabotics project is the development of a comprehensive rehabilitation system to provide highly individualized treatment of upper limb function in patients with motor disorders due to acquired brain damage (eg stroke) or neurodegenerative disease (eg sclerosis), having as central pillar the integration of robotic systems and support functions. A key part of the proposed system is the development and evaluation of an innovative robotic extraskeletal device that will be applied in the form of a glove to the diseased limb of the neurological patient. The proposed robotic system:
- 1.will measure various motor and kinematic parameters of the extremity in order to assess the patient's condition and progress, and
- 2.will offer a specialized rehabilitation program (therapeutic exercises, retraining of functional movements and support of daily activities) through an interactive virtual environment provided by the Rehabotics platform.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2023
CompletedFirst Submitted
Initial submission to the registry
July 9, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedJuly 25, 2024
July 1, 2024
12 months
July 9, 2024
July 19, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Ashworth Scale measured by physiotherapists
This outcome aims to explore the therapeutic potential of Rehabotics in stroke rehabilitation, demonstrating improved hand motor function through the integration of robotics and Augmented Reality games, measured by Ashworth Scale \[AS\]. The AS is a key instrument for evaluating spasticity in individuals with upper extremity mobility challenges during rehabilitation. This assessment uses a scoring system from 0 to 4, where higher scores denote greater difficulty in finger movement, and lower scores indicate easier finger movement.
Change from baseline to 5 weeks
Box and Block Test score measured by physiotherapists
This outcome aims to explore the therapeutic potential of Rehabotics in stroke rehabilitation, demonstrating improved hand motor function through the integration of robotics and Augmented Reality games, measured by the Box and Block Test \[BBT\] score. The BBT consists of a wooden box divided into two compartments by a partition and includes 150 blocks. During the BBT administration, the patient is instructed to move as many blocks as possible, one by one, from one compartment to the other within 60 seconds. The higher the number of blocks moved indicate better manual dexterity.
Change from baseline to 5 weeks
Secondary Outcomes (2)
Device Evaluation Satisfaction utilizing questionnaires for patients
Administered in the 5th week
Device Evaluation Satisfaction utilizing questionnaires for physiotherapists
1 year
Study Arms (2)
Rehabotics Intervention Group
EXPERIMENTALRehabotics Intervention Group received Physiotherapy through the Rehabotics system.
Traditional Physiotherapy Group
ACTIVE COMPARATORTraditional Physiotherapy Group received Physiotherapy.
Interventions
The intervention will be consisted of sessions for participants in the intervention group which includes a repetition of each of the four Sollerman AR Games named, Wallet, Key, Jar, Screwdriver and one repetition of Balloon Pop. Participants will interact with the AR Box and Block Test (BBT) and the serious games under controlled conditions. A clinician will be present throughout the whole session providing help if participants encounter any difficulties. Following the games, the clinician will initiate a stretching program using the Active Exoskeletal Aid, performing 3 sets of 10 repetitions on the finger flexors of the patient's hand. Each rehabilitation session will last 30 minutes and will be conducted three times a week. Similarly, the traditional physiotherapy training program will be prescribed for the control group and will be consisted of sessions lasting 30 minutes per day, three days per week. Both programs duration will be five weeks.
Similarly, the hand functional training program prescribed for the control group consisted of sessions lasting 30 minutes per day, three days per week. Both programs lasted for five weeks and were designed by two clinical experts.
Eligibility Criteria
You may qualify if:
- stroke pathology,
- Ashworth Scale ≤ 3,
- months maximum time since the incident
You may not qualify if:
- Presence of neurological pathologies that affect hand motion (Parkinson's disease)
- Musculoskeletal deficits that affect normal finger range of motion (e.g. finger fractures, joint stiffness/pain, arthritis that affect joint motion)
- Ashworth Scale \> 3,
- Over 6 months since the incident
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pantelis Syringaslead
- University of Ioanninacollaborator
- Physioloft, Physiotherapy Centercollaborator
- University of Peloponnesecollaborator
- Ostracon Ltdcollaborator
Study Sites (1)
Physioloft, Physiotherapy Center
Athens, Attica, 14562, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georgios Papagiannis, PhD
Physioloft
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 9, 2024
First Posted
July 25, 2024
Study Start
November 4, 2022
Primary Completion
November 3, 2023
Study Completion
November 3, 2023
Last Updated
July 25, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
Patient data cannot be provided due to confidentiality and privacy regulations designed to protect individuals' personal information. Upon a formal request, data may be able to be provided anonymized to protect patients' privacy.